Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology*; D004195:Disease Models, Animal; D005340:Fibrinogen / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D005343:Fibrinolytic Agents; D006400:Hematocrit; D006801:Humans; D007422:Intestines / Q000473:pathology; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008297:Male; D010179:Pancreas / Q000473:pathology; D010958:Plasminogen / Q000378:metabolism; D051381:Rats; D013300:Streptokinase; D013917:Thrombin / Q000378:metabolism
D001786:Blood Glucose; D005343:Fibrinolytic Agents; D005340:Fibrinogen; D010958:Plasminogen; D013300:Streptokinase; D013917:Thrombin; D005341:Fibrinolysin